Backed by more than 30 peer-reviewed human clinical studies supporting endogenous antioxidant activity, cellular ...

UT Southwestern Medical Center researchers have identified two lipids that work together with a quintessential protein known ...

The central question is no longer whether we can innovate, but whether innovation can truly reach patients in time.

BackgroundChronic pain is a widespread and debilitating health issue, characterized by pain that persists beyond normal tissue healing. Increasing evidence ...

Diamyd Medical Announces Finalization Of Database For Interim Analysis In Phase 3 DIAGNODE-3 Trial. STOCKHOLM, Feb. 24, 2026 /PRNewswire/ -- The clinical database has been finalized for the pre-specif ...

Significantly less progression, especially unstable lesions, with relugolix versus leuprol ...

People on GLP-1 drugs like Ozempic aren't just losing weight — they're spontaneously seeking out exercise, and neuroscientists believe the drugs are recalibrating the brain's reward system in ways ...

Vice President, Investor Relations at Ascendis Pharma A/S. Joining me on the call today are Jan Moller Mikkelsen, President ...

The clinical database has been finalized for the pre-specified interim efficacy analysis in Diamyd Medical's ongoing pivotal Phase 3 trial (DIAGNODE-3) evaluating retogatein (rhGAD65) in individuals w ...

Pramorelin, also known in scientific literature as a synthetic ghrelin receptor agonist, has emerged as a notable peptide within the broader landscape of endocrine and metabolic research. Its primary ...

A new study explores exercise mimetics as novel therapeutics for depression by triggering muscle-to-brain signals that support mood regulation and resilience.

Disorders of the central nervous system (CNS), including neurodegenerative, ischemic, neuroinflammatory, and traumatic conditions, remain leading causes of ...